Melanie Willows MD, CCFP (AM), CSAM (Certificant), ABAM (Diplomate)
Dr. Willows completed her family medicine residency at Queen’s University following
completion of medical school at the University of Ottawa. Dr. Willows has received certification
by examination from the American Society of Addiction Medicine (2004), has been a certificant
with the Canadian Society of Addiction Medicine since 2005, is diplomat of the American Board
of Addiction Medicine (2014) and has a certificate of added competence in Addiction Medicine
Dr. Willows is an Assistant Professor at the University of Ottawa in the Department of Family
Medicine with a cross-appointment to the Department of Psychiatry. She is an active teacher at
the University of Ottawa providing both didactic lectures to medical students and regular clinical
supervision to medical students, psychiatry residents and family medicine residents.
Dr. Willows provides clinical and academic leadership in addictions and co-occurring disorders
within her department, hospital, and community. She has been working at The Royal Ottawa
Mental Health Centre since 2001 and is the Clinical Director of the Substance Use and
Concurrent Disorders Program. She is a clinical investigator with the Institute of Mental Health
Research (IMHR) with the University of Ottawa.
Dr. Willows provides assessment and treatment for the full spectrum of addictive disorders and
concurrent mental health disorders. She also provides care to healthcare professions through the
Ontario Medical Association Physician Health Program and the Ontario College of Nurses. Dr.
Willows leads several initiatives to build capacity amongst primary care providers and other
health professionals to identify, assess, and treat substance use and co-occurring disorders within
Dr. Willows is committed to collaborating with clinicians and researchers to develop new
services that address gaps in concurrent disorders treatment, with a current focus on women and
transitional aged youth. In 2013, the Ontario Ministry of Health Innovation Fund awarded the
“Best Innovation in Mental Health Care Delivery” to Dr. Willows and her colleague for their
Regional Opioid Intervention Service.
Dr. Willows has been a member of CSAM since 2004 and is currently on the following CSAM
committee(s): Conference and Education.
Dr. Willows has been a CSAM Board Representative from 2012 to present.
Dr. Jennifer Brasch BSc, MD, FRCPC, FCPA
Dr. Jennifer Brasch is an Associate Professor and a member of the Peter Boris Centre for Addictions Research in the Department of Psychiatry and Behavioural Neurosciences at McMaster University . She completed her medical training at Queen’s University in 1991 and a Psychiatry residency at McMaster University in 1996.
Dr. Brasch is Lead, Addiction Psychiatry, for the Mental Health & Addictions Program at St. Joseph’s Healthcare in Hamilton. At St. Joe’s she is the psychiatrist for the Concurrent Disorders Outpatient team and works at the Rapid Assessment Addiction Medicine clinic. She has an opioid agonist therapy practice at the Hamilton Clinic. Dr. Brasch frequently gives educational presentations on addictions and concurrent disorders and supervises medical students and residents. She is the lead for The Reasons to go on Living Project http://www.thereasons.ca/.. She was featured in a video by the OMA for her work in concurrent disorders: https://www.
Dr. Brasch has been a CSAM member since 2013 and Co-chair or Chair of the Scientific Conference Committee since 2017. She participated in the strategic planning process in 2019 and looks forwards to implementing the strategic directions as President.
Paul Sobey MD, CCFP (AM), CSAM (Certificant), DABAM
Dr. Sobey completed medical school at the University of Alberta in 1986, and fellowship training in Addictions at University Hospitals and Case Western Reserve University in Cleveland, Ohio in 1999. He received Board Certification from the American Board of Addiction Medicine in 2010 and became a certificant of the Canadian Society of Addiction Medicine in 2012. Dr. Sobey is a Clinical Instructor at the University of British Columbia Faculty of Medicine, Department of Family Practice. Dr. Sobey has been a CSAM member since 2008, the British Columbia representative to CSAM since 2010, President-Elect from 2013 – 2015, and is the immediate past CSAM President. His practice has been limited to addiction medicine since 1999. He was Lead Physician for the Royal Columbian Hospital Addiction Medicine Service in New Westminster, BC between 2000 and November 2019. He has an active OAT practice in New Westminster and has worked extensively in residential and recovery oriented care. He acts as an Occupational Addiction Medicine consultant to both public and private organizations. Dr. Sobey was the Regional Divisional Lead for Addictions in Fraser Health Authority from April 2011 to May 2013. He was on the Member Advisory Committee on Opiate Dependence – College of Physicians and Surgeons of British Columbia (CPSBC) from 2002 to 2013 and was Chair of the committee from 2011 until 2013. Dr. Sobey is currently sitting on the following CSAM committee(s): Executive, Conference, and Bylaws and is honoured by the opportunity to act on the 2020 conference committee in Victoria, BC.
Laura Evans MD CCFP CSAM (Certificant), ISAM (Certification, ABAM (Diplomate)
Dr. Evans received her MD Degree from McMaster and completed her residency at the St. Paul’s Family Medicine Residency Program, the University of British Columbia in 2007. Her residency focused on marginalized populations in Vancouver and provided her initial training in the medication-assisted treatment of opioid use disorders.
Following residency, and after briefly working in Kamloops BC, Dr. Evans returned to her ‘hometown’ of Winnipeg for four years, where she worked at an inner-city clinic. There, she instigated a primary care based methadone program within the Winnipeg Regional Health Authority.
In 2012, Dr. Evans moved to Calgary Alberta where she transitioned to full-time work across the breadth of Addiction Medicine. Currently, Dr. Evans works at the Alberta Health Services Opioid Dependence Program, at Renfrew Recovery and Detoxification Centre, and provides inpatient addiction consultations at Calgary’s Foothills Hospital. Dr. Evans is passionate regarding her work primarily with adolescents at the outpatient Foothills Concurrent Program. She also works at the Calgary Urban Project Society or ‘CUPS’ Medical Centre providing inner-city primary care integrated with opioid substitution.
Dr. Evans currently sits on the ISAM Exam Editorial Committee, and also teaches residents and medical students across settings, as a Clinical Assistant Professor in the Department of Family Medicine at the University of Calgary.
Dr. Evans has been a member of CSAM since 2013 and is currently on the CSAM Conference and Membership (Chair) committees.
Dr. Evans has been a CSAM Board Representative for Alberta and the North West Territories from 2013 to present.
Naved Ali MD, CCFP, CSAM (Certificant), ABAM (Diplomate)
Dr. Naved Ali MD was born in Edmonton, Alberta and received his MD from the University of Alberta in 1987. After obtaining his CCFP in 1989, he worked in full-service family practice, until eventually focusing on the area of Substance Use and Mental Health. He was certified in Addiction Medicine by ASAM in 1998 and received CSAM certification in 2007 and ABAM Dip status 1n 2009.
Dr. Ali is currently Medical Manager of Stepping Stones in North Vancouver, an outpatient clinic providing services ranging from harm reduction to an intensive abstinence-focused Day Program. He supervises and delivers Day Program groups, and provides both outpatient and inpatient consultations including prescribing Opiate Agonists and other Medication Assisted Treatments. He also has experience working at residential treatment and inpatient detox centres.
Dr. Ali also assesses and treats individuals working in safety-sensitive occupations. He has monitored commercial airline pilots in recovery for the Airline Pilots Association since 2009 and previously worked at the British Columbia Physician Health Program from 2008-2012. He is particularly interested in outcome measurements, as well as workplace policy regarding substance use, misuse and addiction.
In addition to his clinical work, Dr Ali is well respected as an educator. He was the Director of Addiction Medicine at the University of British Columbia from 1996-1998, where he taught the Faculty of Medicine Addiction Medicine curriculum. He continues to supervise students, residents and practising physicians. Dr. Ali is also a sought after speaker, having given over 100 presentations internationally to medical conferences, health care providers, patients and their families, public agencies and private corporations. Most recently, he has been an invited speaker to the annual ALPA Pilots Assistance Forum in Washington, DC where he spoke on the relationship between Trauma and Addiction. Dr. Ali currently lives in Vancouver, British Columbia with his two daughters.
Dr. Ali is in his first term as a CSAM board representative for British Columbia and the Yukon.
Dr. Tanguay is a Psychiatrist who completed 2 fellowships, one in Addiction Medicine and one in Pain Medicine. He is a clinical assistant professor with the departments of Psychiatry and Surgery at the Cumming School of Medicine, University of Calgary. He is the Medical Lead for Alberta Addiction Education for Alberta Health Services. Dr. Tanguay is the Regional Director for Alberta and North West Territories for the Canadian Society of Addiction Medicine (CSAM) and the President of the Pain Society of Alberta. He is the founder of the Opioid Deprescribing Program and the Community Rapid Access Addiction Medicine (RAAM) program with Alberta Health Services and the Transitional Outpatient Pain Program for Spine (TOPPS) clinic working with spinal surgeons to optimize spinal surgery outcomes. Dr. Tanguay is the co-chair of the AHS Alberta Pain Strategy. Dr. Tanguay is also the lead lecturer for Addiction for the Cumming School of Medicine, University of Calgary. Academically he is involved in research in addiction, chronic pain, opioids, and cannabis and is a member of the Hotchkiss Brain Institute and the Mathison Centre for Mental Health Research & Education at the University of Calgary.
Dr. Tanguay has been a member of CSAM since 2015 and is the Alberta & North West Territories Regional Director on the board of CSAM.
Wip Lamba MD, FRCPC, ISAM (Certificant) ABAM (Diplomate)
Dr. Lamba completed his medical school at the University of Ottawa in 2006, his Psychiatry residency at the University of Toronto in 2011, and an addiction fellowship at the Centre for Addiction and Mental Health in 2012.
He is currently the education lead for the addiction program at St. Michael’s Hospital in Toronto where over 50 residents rotate through their service per year. This service involves a multidisciplinary inpatient consultation team including internal medicine, family medicine, emergency medicine, and psychiatry. It also includes a nurse practitioner, peer support and a case manager. They also offer transitional follow-up and psychosocial groups based on motivational interviewing and the community reinforcement approach.
Dr. Lamba’s academic focus is in capacity building in the generalist. He is a member of the education committee at CSAM since 2016, and with Dr. Yelena Chorny led the first buprenorphine course at the CSAM conference in 2017 that was data-sponsored by the American Academy of Addiction Medicine.
Dr. Lamba has been a CSAM Board Representative for Ontario from 2017 to present.
Dr Marsolais completed her training at McGill University in 1996. She completed her residency in family medicine at the Université de Montréal in 1999.Her first 5 years of medical practice started at the emergency, the intensive care and hospitalization units in remote areas of the Province of Québec. She then practiced medicine at the hospitalization pneumology department at Cité de la Santé of Laval for 13 years where she shared her experience with family medicine residents.
Meanwhile, she explored occupational medicine and adopted the practice since 2003. Her interests for addiction medicine started in the workplace where she noticed certain workers with recurrent psychiatric problems with nebulous causes and without treating resources.Therefore, she developed a collaborative procedure with the Union, the employers and the caregivers to understand the causes and the impacts of observed functional issues of workers in their workplace. She has moved societies in the community by popularizing the causes and treatments of addictions and by promoting an inclusive attitude towards workers with addictions in various workplaces. She works as a family and addiction medicine physician in outpatients and inpatients rehabilitation programs. She teaches a course on addictions at the program of certification of disability management practitioner of the Pacific Coast University for Workplace Health Sciences located in British Colombia.
She teaches knowledge of medical follow-ups of workers with addiction issues within a safety- sensitive workplace environment to medical students and residents in occupational medicine of the Université de Montréal. She is involved as a medical consultant at the Association des Intervenants en Dépendances du Québec a non-profit organization gathering various stakeholders working in addictions to promote training and knowledge to workplace’s decision makers. She also acts as a medical examiner for the Medical Council of Canada. She obtained a certification of added competence in addiction medicine granted by the College of Family Physicians of Canada and received the certification of the Canadian Society of Addiction medicine in 2019. She shares her experience and expertise in her community and to medical peers by giving conferences promoting treatment and support to patients and workers suffering of addictions in the objective of maintaining dignity and employability.
Simon Dubreucq MD, FRCFP, MSc
Dr. Dubreucq obtained his medical degree from the University of Montreal in 2008. He completed a psychiatry residency at the University of Montreal in 2013, and a one-year Fellowship at Université Laval in 2014
Dr. Dubreucq is an Assistant Professor of Psychiatry at University of Montreal and works as a psychiatrist in a specialized concurrent disorder clinic at Centre Hospitalier Université de Montréal (CHUM).
He participates in different research projects at the CRCHUM (Centre de Recherche du CHUM) and is involved in the teaching and supervision of pre-graduate medical students, family medicine residents and psychiatry residents.
Dr. Dubreucq has been a member of CSAM since 2016 and has been a Quebec Regional Director on the CSAM board since 2017.
Dave Martell BSC MD CCFP FCFP CISAM CCSAM
Dr. Martell completed undergraduate study at Mount Allison University in 1993, a medical degree at the University of Western Ontario in 1997, and Family Medicine Residency at Dalhousie University in 1999. In 2019, after almost 19 years in General Family Medicine, he transitioned to a career in Addiction Medicine. He lives and works in Lunenburg, Nova Scotia.
Dr. Martell is a Peer Reviewer and serves on the Peer Review Committee of the College of Physicians and Surgeons of Nova Scotia. He is a front line Addiction Medicine provider with the South Shore Opioid Outreach Treatment Team, Direction 180, and Wagmatcook First Nation, all front-line collaborative multi-disciplinary teams. In 2019, he began work on Nova Scotia’s Opioid Use Disorder Practice Support Program, a novel knowledge translation and mentoring support service for primary care collaborative practices in Nova Scotia. He presently serves as Vice Chair of the Addiction Medicine Member Interest Group of the College of Family Physicians of Canada and Addiction Medicine Advisor to the Atlantic Mentorship Network, Pain and Addiction.
Dr. Martell has been a Board Representative for the Maritime Provinces from 2015 to 2019 and presently serves on the CSAM Board as a Member at Large. He also serves as chair of the Policy and Funding Committees.
Selene Etches is a Child and Adolescent Psychiatrist at the IWK Health Centre and an Assistant Professor of Psychiatry at Dalhousie University, Halifax, Nova Scotia. She obtained her MD at the University of Toronto, her psychiatry degree at Dalhousie University and completed further fellowship training in child and adolescent psychiatry at the Centre for Addiction and Mental Health in Toronto. Her time is split between working as an Emergency and hospital inpatient consultant liaison psychiatrist as well as physician lead of the Concurrent Disorders Specific Care Clinic at the IWK. She is also involved in teaching psychiatric and pediatric residents and medical students at Dalhousie University. Current research interests include outcome evaluations of patients with concurrent disorders, risk and protective factors in adolescent substance users (particularly the impact of past trauma), sleep disturbances in substance users, primary prevention programs, tertiary program development, and staff/family/community education.
Wael Shublaq M.B.B.CH, PhD, Dip. OB/GYN,
Dr. Shublaq completed his M.B.B.CH training in Alexandria, Egypt in November 1983. His Diploma of Speciality (1994) and his PhD (1995) both in OB/GYN were completed in Wroclaw, Poland.
In 2002, Dr. Wael moved to Newfoundland, Canada and completed his Clinical Associate Neurosurgery by 2009. He entered a Residency Training Program – Psychiatry – MUN from 2009 – 2011 which is not completed.
Dr. Shublaq was a GP in the Mental Health and Addictions Program, Psychiatry Department in Newfoundland from 2011 – 2015. He is currently a Family GP with a solo practice clinic, and a methadone prescriber in the ODT Centre, in St. John’s, NL.
He has been a peer reviewer for the Journal of Addiction Medicine.
Dr. Shublaq has been a member of CSAM since 2011 and has represented the board as the Newfoundland Regional Director since 2012. 2019 granted the certificate of added competence in Family Medicine – Addiction Medicine.
Nady el-Guebaly C.M., MD, FRCPC, DPH, DPsych, DFASAM, DFAAAP, EFACP, DFCPA, CSAM (Certificant),
ABAM (Diplomate), ISAM (Certificant)
Dr. el-Guebaly’s introduction to mental health and addiction medicine dates back to 1969 during initial
psychiatric training in the United Kingdom, followed by training in Canada and the United States.
Addiction related work includes currently being Professor Emeritus, Department of Psychiatry at the
University of Calgary, and the founding past Medical Director of the Calgary Health Region Addiction
Centre and Program. Dr. el-Guebaly was the past President of the Canadian Psychiatric Association and the
Canadian Society of Addiction Medicine, Founding Past President of the International Society of Addiction
Medicine, its Executive Medical Director for another 6 years, and currently Chief Examiner of the
International Certification Examination and Senior Editor of the Textbook of Addiction Treatment:
International Perspectives (2 nd edition, Springer Nature 2020).
Dr. el-Guebaly completed three 3-year terms as Board Chair of the Alberta Gaming Research Institute, and
then Research Director of the Alberta Gambling Research Institute. He is the Editor in Chief of the
Canadian Journal of Addiction for the last 8 years.
These interests have resulted in over 280 peer-reviewed papers, 80 chapters, 591 presentations, and 60
past and current grants totaling $7 million.
He is a member, of the Provincial Addiction Curricula and Experiential Skills Training for Alberta Health
Services, and currently the ISAM-CSAM Conference Committee.
Ron Fraser MD, CSPQ, FRCPC
Dr. Fraser received his medical degree from Dalhousie University in Halifax, Nova Scotia in 1995 and completed his psychiatry residency at McGill University in Montreal, Quebec in 2000. He completed a fellowship in addiction psychiatry at McGill in 2001. Dr. Fraser is currently an Associate Professor of Psychiatry at McGill and an Adjunct Professor of Psychiatry at Dalhousie.
Dr. Fraser is the head of the inpatient detoxification service and an attending staff physician on the Addictions Unit of the department of psychiatry at the McGill University Health Center (MUHC). He is also the medical director of the Long Term Treatment Program for Borderline Personality Disorder in the Department of Psychiatry at the MUHC. Additionally, he is co-medical director for Homewood du Plateau in Montreal.
Dr. Fraser has a special research interest in the interface between addiction and personality disorders.
Dr. Fraser has been a member of CSAM since 2014. He is on the education committee and the annual conference committee and has been a regional board director for Quebec since 2015.
Claudette Chase MD, FCFP
Dr. Chase completed her training at McMaster University in 1992. She completed a residency in Rural Family medicine through the University of British Columbia in 1994. She obtained her Fellowship from the College of Family Physicians of Canada Fellowship in 2003 and has received a Fellowship of Rural and Remote Medicine from the Society of Rural Physicians of Canada
She has held many leadership roles, including being the president of the Ontario College of Family Physicians from 2002 to 2003. Dr. Chase is currently affiliated with the Northern Ontario School of Medicine and in the past has been the family medicine director McMaster University from 2005-2006.
Dr. Chase helped pioneer and still manages a community-based addiction treatment program in a remote First Nation. She is also involved with a treatment team that serves the First Nation high school in Thunder Bay, and two other First Nations.
She serves on the Ontario Ministry of Health Committee, Methadone Treatment and Services Advisory Committee, and the Adult Chronic Pain Advisory Board. She has presented on addiction treatment at Family Medicine Forum for the past three years, and at the CPSO in 2013 and 2014.
Dr. Chase has been a member of CSAM since 2013 and is currently on the CSAM Membership committee. She has been on the CSAM board as a Member at Large since 2015.
George Budd Pharm.D, FBCCSU, B.Sc.(Pharm.), R.PEBC, R.Ph.
George P. Budd, a practicing pharmacist since 1992 from Cairo University, further obtained his Doctor of Pharmacy degree in 2011 from Idaho State University. He has experience in many different practice settings within the profession such as hospital pharmacy residency, community pharmacy and as a pharmacist-manager in community settings. Former Senior Investigator for the College of Pharmacists of BC (CPBC), and formally a Professional Conduct Review Consultant/Policy Liaison with the BC College of Nursing Professionals (BCCNP). Currently a Research Associate at Vancouver Coastal Health (VCH) and a member of the Complex Pain and Addiction Services Team at Vancouver General Hospital.
George is on the Board of Directors of the Canadian Society of Addiction Medicine (CSAM), a public member on the Professional Practice Standards at BCCNP, a Past-President of the Western Canada Addiction Society, and a former public representative to the Methadone Panel and the Prescription Review Program at the College of Physicians and Surgeons of BC.
Additionally, he has been a representative on National and Provincial advisory committees such as CCSA National Dialogue on Prescription Drug Misuse, Opioid Substitution Treatment Psychosocial Service Framework and many other.
George is the first pharmacist to complete a Pharmacy Addiction Fellowship at the BC Centre on Substance Us (BCCSU) and is dedicated to establishing best practices in the area of addiction medicine. He worked closely with addiction physicians and members of other disciplines that share a strong belief in collaboration as a key to achieving desired health outcomes
Monty Ghosh is an Internist and Addiction Specialist who works at the University of Alberta Hospital in Edmonton as an Internist as well as the Sheldon Chumir and Rockyview Hospitals doing Addiction Medicine in Calgary. He works with multiple community based not for profit organizations to provide support for marginalized populations including The Alex and The Calgary Drop-In Centre. He also helps foster and create unique programs to support those living with substance use, experiencing homelessness, and with other vulnerabilities.
He is an assistant clinical professor at both The University of Alberta and the University of Calgary, and is heavily involved with provincial policy building in Alberta, as well as with research and is the recipient or co-recipient of grants from Alberta Innovates, Alberta Health, and the Canadian Institute of Health Research.